Published in Biochim Biophys Acta on August 01, 2005
An intracellular lamellar-nonlamellar phase transition rationalizes the superior performance of some cationic lipid transfection agents. Proc Natl Acad Sci U S A (2006) 1.07
Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene. Mol Vis (2007) 0.92
Lipoplex formulation of superior efficacy exhibits high surface activity and fusogenicity, and readily releases DNA. Biochim Biophys Acta (2006) 0.92
Intracellular trafficking of cationic liposome-DNA complexes in living cells. Soft Matter (2012) 0.85
The Conventional Langmuir Trough Technique as a Convenient Means to Determine the Solubility of Sparingly Soluble Surface Active Molecules: Case Study Cholesterol. Colloids Surf A Physicochem Eng Asp (2008) 0.81
Bioreducible liposomes for gene delivery: from the formulation to the mechanism of action. PLoS One (2010) 0.81
Effect of spacer attachment sites and pH-sensitive headgroup expansion on cationic lipid-mediated gene delivery of three novel myristoyl derivatives. Biophys Chem (2007) 0.80
Synergy in lipofection by cationic lipid mixtures: superior activity at the gel-liquid crystalline phase transition. J Phys Chem B (2007) 0.76
Transferrin-associated lipoplexes as gene delivery systems: relevance of mode of preparation and biophysical properties. J Membr Biol (2008) 0.75
Nucleic acid-lipid membrane interactions studied by DSC. J Pharm Bioallied Sci (2011) 0.75
Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. Biochim Biophys Acta (2004) 1.56
Destruction thresholds of echogenic liposomes with clinical diagnostic ultrasound. Ultrasound Med Biol (2007) 1.35
Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents. Ultrasound Med Biol (2002) 1.29
Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release. J Am Chem Soc (2006) 1.27
In vitro characterization of liposomes and Optison by acoustic scattering at 3.5 MHz. Ultrasound Med Biol (2004) 1.13
Lipid bilayer vesicle fusion: intermediates captured by high-speed microfluorescence spectroscopy. Biophys J (2003) 1.09
Fibrin targeting of tissue plasminogen activator-loaded echogenic liposomes. J Drug Target (2007) 1.07
An intracellular lamellar-nonlamellar phase transition rationalizes the superior performance of some cationic lipid transfection agents. Proc Natl Acad Sci U S A (2006) 1.07
Cubic phases in phosphatidylcholine-cholesterol mixtures: cholesterol as membrane "fusogen". Biophys J (2006) 1.03
Lipid phase control of DNA delivery. Bioconjug Chem (2005) 0.99
Liposomes as ultrasound imaging contrast agents and as ultrasound-sensitive drug delivery agents. Cell Mol Biol Lett (2002) 0.99
Novel echogenic drug-immunoliposomes for drug delivery. Invest Radiol (2004) 0.98
Quantitative immunoblot assay for assessment of liposomal antibody conjugation efficiency. Anal Biochem (2002) 0.95
Transfection activity of binary mixtures of cationic o-substituted phosphatidylcholine derivatives: the hydrophobic core strongly modulates physical properties and DNA delivery efficacy. Biophys J (2006) 0.93
DNA release from lipoplexes by anionic lipids: correlation with lipid mesomorphism, interfacial curvature, and membrane fusion. Biophys J (2004) 0.93
Effects of microtubule-depolymerizing agents on the transfection of cultured vascular smooth muscle cells: enhanced expression with free drug and especially with drug-gene lipoplexes. Mol Ther (2004) 0.93
Lipoplex formulation of superior efficacy exhibits high surface activity and fusogenicity, and readily releases DNA. Biochim Biophys Acta (2006) 0.92
Mixtures of cationic lipid O-ethylphosphatidylcholine with membrane lipids and DNA: phase diagrams. Biophys J (2003) 0.92
Encapsulation of NF-kappaB decoy oligonucleotides within echogenic liposomes and ultrasound-triggered release. J Control Release (2009) 0.90
Synthesis, acoustic stability, and pharmacologic activities of papaverine-loaded echogenic liposomes for ultrasound controlled drug delivery. J Liposome Res (2008) 0.89
Modulation of a membrane lipid lamellar-nonlamellar phase transition by cationic lipids: a measure for transfection efficiency. Biochim Biophys Acta (2008) 0.87
Cationic O-ethylphosphatidylcholines and their lipoplexes: phase behavior aspects, structural organization and morphology. Biochim Biophys Acta (2003) 0.87
High temperature stabilization of DNA in complexes with cationic lipids. Biophys J (2002) 0.86
Thermodynamics of cationic lipid-DNA complex formation as studied by isothermal titration calorimetry. Biophys J (2002) 0.86
Natural lipid extracts and biomembrane-mimicking lipid compositions are disposed to form nonlamellar phases, and they release DNA from lipoplexes most efficiently. Biochim Biophys Acta (2007) 0.85
Lipoplex thermodynamics: determination of DNA-cationic lipoid interaction energies. Biophys J (2003) 0.82
Fusion peptides promote formation of bilayer cubic phases in lipid dispersions. An x-ray diffraction study. Biophys J (2013) 0.82
Effects on interactions of oppositely charged phospholipid vesicles of covalent attachment of polyethylene glycol oligomers to their surfaces: adhesion, hemifusion, full fusion and "endocytosis". J Membr Biol (2008) 0.79
Novel polyamine-dialkyl phosphate conjugates for gene carriers. Facile synthetic route via an unprecedented dialkyl phosphate. Bioconjug Chem (2004) 0.78
Synergistic effect between components of mixtures of cationic amphipaths in transfection of primary endothelial cells. Mol Pharm (2007) 0.78
Novel fluorescent cationic phospholipid, O-4-napthylimido-1-butyl-DOPC, exhibits unusual foam morphology, forms hexagonal and cubic phases in mixtures, and transfects DNA. Chem Phys Lipids (2004) 0.77
Cationic phospholiposomes: efficient delivery vehicles of anticancer derivatives of ATP to multiple myeloma cells. J Liposome Res (2011) 0.76
Single lipoplex study of cationic lipoid-DNA, self-assembled complexes. Mol Pharm (2007) 0.76
Synergy in lipofection by cationic lipid mixtures: superior activity at the gel-liquid crystalline phase transition. J Phys Chem B (2007) 0.76